Truist Financial Corp Quidel Ortho Corp Transaction History

Truist Financial Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 01, 2023	SELL	$81.09 - $94.16 $182,452 - $211,860	-2,250 Reduced 30.16%	5,209 $431,000
Q1 2023 May 05, 2023	SELL	$82.98 - $91.46 $397,806 - $438,459	-4,794 Reduced 39.13%	7,459 $664,000
Q4 2022 Feb 17, 2023	BUY	$66.93 - $97.5 $280,972 - $409,305	4,198 Added 52.12%	12,253 $1.05 Million
Q3 2022 Oct 26, 2022	SELL	$69.86 - $107.63 $155,927 - $240,230	-2,232 Reduced 21.7%	8,055 $575,000
Q2 2022 Jul 22, 2022	BUY	$89.06 - $117.64 $916,160 - $1.21 Million	10,287 New	10,287 $1 Million

293

67.9M

337K

134K

Ticker QDEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 66,952,900
Market Cap $2.75B
Description
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Truist Financial Corp with notifications on news.